Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals
申请人:AstraZeneca AB
公开号:US06303613B1
公开(公告)日:2001-10-16
There are provided novel compounds of formula (I)
wherein:
A represents a five membered heterocyclic aromatic ring containing 1 to 3 heteroatoms which may be the same or different and are selected from O, N and S; or a six membered heterocyclic aromatic ring containing 1 to 3 nitrogen atoms; and R1, R2, R3 and R4 are as defined in the Specification and pharmaceutically acceptable salts thereof and enantiomers and tautomers thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
提供了式(I)的新化合物
其中:
A代表含有1至3个杂原子(可以相同也可以不同,选自O、N和S)的五元杂环芳香环,或者含有1至3个氮原子的六元杂环芳香环;而R1、R2、R3和R4如规范中所定义,以及其药学上可接受的盐、对映体和互变异构体;以及它们的制备方法、含有它们的组合物以及它们在治疗中的用途。这些化合物是一氧化氮合酶的抑制剂,因此在治疗或预防炎症性疾病和疼痛方面特别有用。